Hosted on MSN
Cancer vaccine slashes risk of deadly skin cancer returning by nearly half in major trial
Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of their disease returning by almost half. Melanoma is one of the most aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results